Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Luveris Addition to GONAL-f in IVF (Day 1 vs Day 6)
NCT01497197Phase 3Terminated
- Sponsor
- Merck KGaA
- Start
- May 2012
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lutropin alfa in infertility (2 arms), sponsored by Merck KGaA. Primary endpoint: Total Number of Oocytes Retrieved Per Subject Following Ovarian Stimulation. Started May 2012; status: terminated.
02
Drugs
lutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01497197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497197.